Sectors
-
Neptune Digital Assets Sells Free Ionic Digital Shares for $234,000
A Vancouver crypto holding company just turned a free stock windfall into over two hundred thousand dollars without spending a cent to acquire it. In Toronto, a fintech company that posted its first-ever profitable quarter this spring just raised its own revenue forecast by up to $30 million, based on a single month of sales.…
-
IsoEnergy Forms $105M-Backed DISA Uranium Venture as Two Clean Energy Stocks Slide on Fresh Disclosures
A Toronto uranium miner just handed off a chunk of its Utah portfolio to a brand-new company backed by $105 million from strategic investors including a mining major and an oilfield services giant. A battery materials company’s own financing announcement knocked more than 20% off its stock the next day. And a solar technology company…
-
BriaCell’s FDA Clearance for Bria-PROS+ Adds a Fourth Active Immunotherapy
BriaCell just added a fourth active immunotherapy program to a pipeline that already has one candidate in Phase 3. The FDA didn’t blink. Two names covered here last week did get their answers this week, and the answers landed nothing alike, one company watched its stock double, the other is now talking about suing its…
-
Alchemy Labs Expands ExoShield to the Ford F-Series, Plus Two Other Small-Cap Tech Moves
Alchemy Labs went public less than a month ago selling windshield film and defense coatings out of the same balance sheet, and it just added one of the best-selling trucks in North America to its customer list. A post-quantum cybersecurity company that still books well under $50,000 a year in revenue just pulled in $5.3…
-
Canada Nickel Wins Crawford Approval, Extends Loan for Third Time
Canada Nickel received the first mining approval issued under Canada’s amended Impact Assessment Act on July 31, an approval the company says clears the way toward $70 billion in GDP contribution over the life of its Crawford project. Three days earlier, the same company extended a bridge loan for the second time this year, paying…
-
Capricor’s Deramiocel Voted Down 9-3 by FDA Advisory Panel
Nine advisory committee members looked at the same trial data Capricor called a win and voted against it. The 9-3 result on July 29 didn’t kill Capricor’s Duchenne muscular dystrophy program, but it added a real question mark to a therapy the company insists already cleared its bar. INmune Bio spent the same stretch doing…
-
SunPower’s Q2 Revenue Falls 23% on Self-Imposed Quality Holds
SunPower held back $15.3 million of already-signed, already-financed jobs from its own second quarter, on purpose, over blurry photos and missing utility bills. The company reported the results anyway on July 28. Revenue came in at $56.0 million, down 23% from the prior quarter, and the stock kept sliding toward $0.31, a level that makes…
-
Strategy’s $8.22B Loss and Coinbase’s Record Market Share
Strategy and Coinbase reported second-quarter earnings within hours of each other on July 30. Strategy’s loss ran into the billions, almost entirely a paper markdown on bitcoin it has no plans to sell. Coinbase’s loss was smaller and came with a record trading-volume market share attached. Both stocks fell anyway. Strategy Posts an $8.22 Billion…
-
America’s Antimony Push Gets a Pilot Plant. One Junior Is Already Finding More
The U.S. Army and Idaho National Laboratory opened a modular pilot plant in Idaho Falls built to process antimony, a mineral used in ammunition, batteries, and flame retardants that the United States currently gets almost entirely from China and Russia. A day earlier, a small New Brunswick company reported another round of high-grade antimony assays…









